Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01996293 · ClinicalTrials.gov registry record
Pregnant Women Taking Lamictal for Bipolar Disorder
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 30
- Enrollment target
NCT01996293 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 30 participants.
The verdict
NCT01996293 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study seeks to examine how the dose of lamotrigine (Lamictal) should be adjusted during pregnancy for women with Bipolar Disorder. The investigators predict that the concentration of Lamictal in women's blood will decrease during pregnancy, and increase after postpartum. Because the concentration of the medication is likely to decrease during pregnancy, it is important for doctors to know how much they should increase a patient's dose in order to prevent worsening of Bipolar symptoms. In this study, the investigators will ask that participants complete up to five overnight visits to our clinical research unit where their blood will be drawn every couple of hours, through an IV catheter, to measure how the concentration of lamotrigine (Lamictal) changes over time. Participants will be compensated for their time.
Interventions
- DRUG lamotrigine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-09 |
| Est. Completion | 2020-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01996293
The ClinicalTrials.gov registry entry for NCT01996293 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lamotrigine is the first listed.
NCT01996293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01996293 about?
NCT01996293 is a clinical study titled "Pregnant Women Taking Lamictal for Bipolar Disorder". This study seeks to examine how the dose of lamotrigine (Lamictal) should be adjusted during pregnancy for women with Bipolar Disorder. The investigators predict that the concentration of Lamictal in women's blood will decrease during pregnancy, and increase after postpartum. Because the concentrati...
What is the current status of trial NCT01996293?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2013-09. Estimated completion is 2020-12.
What interventions are being tested in trial NCT01996293?
The interventions under investigation include: lamotrigine (DRUG).
Who is sponsoring clinical trial NCT01996293?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.